Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grell

Showing results (501-510 of 543) with videos related to

Pageof 55
Sort By:
Leukemia|April 10, 2020
Correction: Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology studyMaria Thastrup, Hanne Vibeke Marquart, Mette Levinsen, et al.
Leukemia|September 20, 2019
Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology studyMaria Thastrup, Hanne Vibeke Marquart, Mette Levinsen, et al.
Mutation Research|February 7, 2001
Chromosomal aberrations of blood lymphocytes induced in vitro by radon-222 daughter alpha-irradiationJ Pohl-Rüling, H Lettner, W Hofmann, et al.
BMC Cancer|March 3, 2019
Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancerCornelia Schroeder, Jan Grell, Claudia Hube-Magg, et al.
Ugeskrift for Laeger|September 6, 1982
[Long-term treatment with epidural opiates. A multicenter account of 125 patients]H B Andersen, D Benveniste, L Bitsch-Larsen, et al.
Mabs|October 4, 2024
A comparative study of the developability of full-length antibodies, fragments, and bispecific formats reveals higher stability risks for engineered constructsItzel Condado-Morales, Fabian Dingfelder, Isabel Waibel, et al.
British Journal of Pharmacology|October 9, 2025
Leveraging the ADAM10 prodomain for selective inhibition to enhance recovery after myocardial infarctionErik Klapproth, Johanna Marks, Patrick Diaba-Nuhoho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2015
Cutting Edge: identification of neutrophil PGLYRP1 as a ligand for TREM-1Christine B Read, Joseph L Kuijper, Siv A Hjorth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2025
A Phase I Dose-Escalation Study of the HIF-2 Alpha Inhibitor DFF332 in Patients with Advanced Clear-Cell Renal Cell CarcinomaSumanta K Pal, Alice Bernard-Tessier, Peter Grell, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|June 26, 2012
[Triple-negative breast cancer: analysis of patients diagnosed and/or treated at the Masaryk Memorial Cancer Institute between 2004 and 2009]M Svoboda, J Navrátil, P Fabian, et al.
Pageof 55

Showing results (501-510 of 543) with videos related to

Sort By:
Pageof 55
Leukemia|April 10, 2020
Correction: Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology studyMaria Thastrup, Hanne Vibeke Marquart, Mette Levinsen, et al.
Leukemia|September 20, 2019
Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology studyMaria Thastrup, Hanne Vibeke Marquart, Mette Levinsen, et al.
Mutation Research|February 7, 2001
Chromosomal aberrations of blood lymphocytes induced in vitro by radon-222 daughter alpha-irradiationJ Pohl-Rüling, H Lettner, W Hofmann, et al.
BMC Cancer|March 3, 2019
Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancerCornelia Schroeder, Jan Grell, Claudia Hube-Magg, et al.
Ugeskrift for Laeger|September 6, 1982
[Long-term treatment with epidural opiates. A multicenter account of 125 patients]H B Andersen, D Benveniste, L Bitsch-Larsen, et al.
Mabs|October 4, 2024
A comparative study of the developability of full-length antibodies, fragments, and bispecific formats reveals higher stability risks for engineered constructsItzel Condado-Morales, Fabian Dingfelder, Isabel Waibel, et al.
British Journal of Pharmacology|October 9, 2025
Leveraging the ADAM10 prodomain for selective inhibition to enhance recovery after myocardial infarctionErik Klapproth, Johanna Marks, Patrick Diaba-Nuhoho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 18, 2015
Cutting Edge: identification of neutrophil PGLYRP1 as a ligand for TREM-1Christine B Read, Joseph L Kuijper, Siv A Hjorth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2025
A Phase I Dose-Escalation Study of the HIF-2 Alpha Inhibitor DFF332 in Patients with Advanced Clear-Cell Renal Cell CarcinomaSumanta K Pal, Alice Bernard-Tessier, Peter Grell, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|June 26, 2012
[Triple-negative breast cancer: analysis of patients diagnosed and/or treated at the Masaryk Memorial Cancer Institute between 2004 and 2009]M Svoboda, J Navrátil, P Fabian, et al.
Pageof 55